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1. Introduction
1.1. Defining the concepts underlying differences in emotional reactivity
The existence of stable individual differences in cognitive and emotional capabilities both in
animals and humans is well-accepted. The theories of personality assume that such individ‐
ual differences can be categorized and that the richness of individual differences in humans
would be the result of the combination of differences in a few underlying personality fac‐
tors. The most accepted contemporary theory is that of “Big Five” [1] that consider five high‐
est order factors: neuroticism, extraversion, openness, agreeableness and conscientiousness.
However, the nature of some of the putative factors is still a matter of dispute in the differ‐
ent theories. Within this framework, the factors extraversion and neuroticism have been as‐
sociated to the response to positive and negative emotions, respectively. Moreover, it is
typically distinguished between personality and temperament, the latter term referring to
biological predisposition that is noted early in life and will eventually lead to adult person‐
ality [2]. Emotionality may be considered as relatively stable individual characteristic so that
subjects labeled as highly emotional will strongly react to emotional stimuli, particularly
negative ones. It is of interest to know how high neuroticism subjects react to stressful situa‐
tions and which are the consequences of such exposure. It has been reported that in re‐
sponse to an adverse event high neuroticism soldiers showed larger increases in psychiatric
symptoms than low neuroticism subjects [3], but no differences in the response were ob‐
served after controlling for pre-trauma symptoms. These data question the existence of high
stress responsiveness in high neuroticism subjects.
In animals, the concept of emotionality is associated with the response to aversive stimuli.
On the basis of the study of the behavioral and physiological responses to emotional situa‐
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tions, it may be concluded that emotional reactivity is clearly multifactorial. For instance,
neither behavioral nor physiological responses, all of them presumably related to this con‐
cept, follow a uniform pattern when different strains of rats are compared [4]. The obvious
conclusion is that emotionality is a complex, multifactorial, concept [4] and that emotional
stimuli are probably processed in parallel brain circuits thus resulting in a wide range of as‐
sociated physiological responses.
For the purpose of the present review we will focus on individual differences in anxiety.
This is a particular emotional characteristic that has attracted considerable attention for the
important role of anxiety disorders in humans. It is generally distinguished between the
concepts of trait and state anxiety. The first refers to a stable predisposition to react with low
or high levels of anxiety in response to anxiety-provoking stimuli, whereas the second eval‐
uate the actual reaction to a particular situation. Some classical psychometric test distinguish
between both, for instance the trait-state anxiety Spielberger test or STAI [5], trait anxiety be‐
ing a general predisposition to get higher levels of state anxiety when confronted with aver‐
sive situations. The distinction between trait and state anxiety is particularly difficult in
animal models, although some authors assumed, in line with the concept in humans, that
animals characterized by high levels of trait anxiety should show high levels of anxiety-like
behaviour in response to different tests, as it is the case of BALB/c inbred mice [6]. There is
no consensus about putative tests that can specifically evaluate differences in trait anxiety in
animals. Another important theoretical consideration is the distinction between normal and
pathological anxiety, the latter one reflecting merely the extreme of a continuum, or on the
contrary qualitative differences with the normal population. This distinction is basically im‐
possible to establish in animal models.
When discussing about animal models, it is important to distinguish between those that in‐
volve certain environmental or genetic manipulations aimed to develop high anxious indi‐
viduals or those aiming at evaluating anxiety-like behaviour in particular individuals. We
referred to the latter as tests for anxiety or anxiety-like behaviour. There are different animal
tests for anxiety. Some of them involve unconditioned response to aversive stimuli, whereas
others imply conditioned responses [6]. Even when unconditioned tests, which usually in‐
volve evaluation of the free behaviour of animals, are used there are many instances of dis‐
sociation in the outcomes of the different tests when comparing groups of animals [i.e. 7].
This suggests that each test probably evaluate situational-specific components of anxiety. In
fact, factorial analysis sometimes supports that putatively underlying factors determining
behaviour are likely to differ in great part across tests [i.e. 8,9]. This is important when con‐
sidering the putative relationship between anxiety and physiological parameters to be dis‐
cussed later. Nevertheless, marked differences in trait-anxiety, either of environmental or
genetic origin, may result in important differences in several different behavioral tests [i.e.
10,11], suggesting partially common underlying factors.
It is now widely-accepted that there are conceptual differences between fear and anxiety in
that fear is elicited by precise and temporally defined dangers (the presence of a predator,
exposure to well-announced aversive stimuli such as electric shocks), whereas anxiety
would be elicited by more diffuse and sustained dangers (contextual fear conditioning,
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predator odours, unpredictable aversive stimuli) [12, 13]. Nevertheless, it is still difficult to
be sure whether behaviour of animals in novel environments is related to fear or anxiety.
For instance, rats and mice have innate aversion for open spaces, likely to be related to the
risks of being predated in such places. Can then we speak about fear (innate predisposition)
or about anxiety so far as the open spaces is only potentially nor actually dangerous? This is
important as several widely used anxiety tests are based on exposure to novel environments
such as the elevated plus-maze (EPM) or the light-dark (or dark-light) tests [14-17]. The EPM
consists of a plus-maze elevated over the floor, with two (closed) arms surrounded by walls
and other two unprotected. The light-dark apparatus has two compartments, one small and
dark and another much greater and illuminated. In the light-dark version we initially put
the animals into the illuminated area and measure time spent to entry for the first time in
the dark compartment, the number of transitions between light and dark and the time spent
in each compartment. In the dark-light version, the animals are introduced into the dark
compartment and we measure the latency to enter into the illuminated area and the other
measures previously indicated. The EPM and light-dark test are based on the fear elicited in
rodents (which are nocturnal animals) by open and illuminated spaces, and the natural ten‐
dency of these animals to explore new environments. These two tendencies generated a con‐
flict and we expect that less emotional, fearless or low anxiety animals spend more time in
the open arms of the EPM and the illuminated area of the light-dark test. Other animal mod‐
els are based on the performance in an active avoidance-escape task in a shuttle box. In this
task the imminence of a shock is signalled by a specific conditioned stimulus (noise, light;
CS) and the animals can learn to avoid the shock (during the CS) or escape from the actual
shock by doing a particular active behaviour: jumping from one side to the other. This pro‐
cedure likely elicits an emotional reaction close to fear. However poor performance in such
task is considered to be associated to high anxiety that makes the animals to become immo‐
bile and perform poorly. Administration of classical anxiolytic drugs clearly improves per‐
formance [i.e. 18]. The extent to which psychological dimensions underlying individual
differences are similar in all cases or whether or not we are really detecting differences in
anxiety is still an open question.
In addition to the problem of correctly indentifying a particular behavioral trait, there are
problems related to the characterization of the physiological profiles associated to such a
trait. First, negative emotional situations elicit a wide range of physiological responses and it
is important to know whether or not such repertoire of responses is dependent of the partic‐
ular stimulus or the particular emotion elicited. Until now it has not been possible to conclu‐
sively identify physiological response patterns associated to specific emotions. Second, the
emotional response to particular situations are greatly influenced by the cognitive process‐
ing of the particular stimulus (appraisal) and by coping strategies, that is the behavioral rep‐
ertoire used for the animals to escape from the source of the aversive experience or to reduce
the impact of the situation. Koolhaas [19] considered coping style as a set of coherent behav‐
ioral and physiological responses to aversive stimuli. Two different coping styles have been
defined: proactive (active) and reactive (passive), characterized by the triggering of active
versus passive strategies to cope with aversive situations. The authors considered coping
style as independent of emotionality [19,20]. That is, the dimension of active versus passive
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strategies is considered as orthogonal to emotionality. Nevertheless, coping style can influ‐
ence the success of the strategy used to face the situation and, indirectly, the behavioral and
physiological response to the situation. Therefore, it is difficult to establish putative relation‐
ship between physiological variables and emotionality, including anxiety, without knowing
other dimensions of personality as coping style.
It should be also taken into account that even if we can isolate one particular trait such as
anxiety, the final behavioral and physiological responses (measurable outputs) are the result
of the activation (or inhibition) of a wide range of divergent brain pathways, each of them
putatively influenced by individual characteristics not related to the trait of interest, which
may perturb or mask the common influence (trait) on all these variables. For instance, if we
evaluate emotional reactivity by the activity of animals in a novel environment, even if two
animals experienced the same level of fear/anxiety, the expression of the final measured re‐
sponse (ambulation, rearing) could differ because of different in activity, coping strategies
(active or passive) or other traits (i.e. interest for novelty). Available evidence indicates that
the genetic control of anxiety appears to be polygenic (as it is the case of other behavioral
traits). Similar conclusion applies to the control of certain physiological parameters impor‐
tant for the present issue, as it is the case of the hypothalamic-pituitary-adrenal (HPA) axis
[21]. By definition, inbred rats are genetically homogeneous and homozygotic for all genes.
This means that every inbred strain has only a particular allele for each gene among the var‐
ious ones present in the species and that throughout the process of inbreeding, a particular
allele of each gene involved in the behavioral trait of interest or in the activity of the HPA
axis has been randomly fixed. As it can be assumed that the genes are controlling each par‐
ticular function in both positive and negative directions, each particular inbred strain could
have been fixed a different combination of the alleles involved in the functions of interest.
Therefore, it may be theoretically difficult to find a relationship between a behavioral trait
and the HPA axis that may apply to other inbred strains or to an outbred population of rats.
That is why we will refer only in very specific cases to studies with inbred rats or mice.
1.2. An overview of the HPA axis and other physiological stress markers
The present review will focus on the relationship between anxiety and the sympathetic-me‐
dullo-adrenal (SMA) and hypothalamic-pituitary endocrine axes. In the latter case, special
attention should be given to the HPA axis and prolactin because they are considered as
good biological markers of stress (see below). Activation of the SMA and HPA axes consti‐
tute the prototypical physiological responses to stressors in all vertebrates. These two axes
have focused great attention in the field of stress for two main reasons [22]. First, the release
of SMA and HPA hormones into blood is positively related to the intensity of the stressful
situations and therefore they are well-suited to reflect differences among subjects in the de‐
gree of emotional activation. Second, activation of the SMA axis have a critical role in the
regulation of metabolism and cardiovascular responses and is likely to be important for the
development of certain stress-related pathologies (i.e. hypertension). Third, glucocorticoids
(cortisol in humans and most mammals; corticosterone in rats and mice), the final output
hormone of the HPA axis, has been implicated in a wide range of pathophysiological and
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psychopathological processes, including cardiovascular diseases, immune suppression, al‐
tered gastrointestinal function, anxiety disorders, depression and predisposition to drug
self-administration. However, It is now well-recognized that stress-induced pathology is not
only dependent on the nature and time-schedule of exposure to stressors but on individual
differences in vulnerability to them.
The association  between the  activation  of  the  SMA axis  and stress  is  well-known since
the earlier works by Cannon in the first half of the XX century. However, it is now real‐
ized that stress exposure also resulted in the activation of certain responses mediated by
the parasympathetic  nervous system.  For  instance,  changes  in  intestinal  colonic  motility
and visceral pain sensitivity [i.e. 23-25]. Moreover, the old idea that the SMA axis is acti‐
vated in an all or none manner is not accepted as there are strong anatomical and func‐
tional  evidence for  a  fine tuning of  the response of  SMA to different  stimuli,  including
stressors [26, 27]. The flexibility of the SMA axis to respond to different stimuli is on the
basis  of  the theories  that  argue that  different  emotions in humans can be distinguished
by a particular physiological  signature,  nevertheless,  there is  not at  present unequivocal
and precise evidence for such signature [28]. Activation of the SMA axis have been typi‐
cally  evaluated  measuring  plasma  (or  urinary)  levels  of  noradrenaline  and  adrenaline,
heart rate (HR), heart rate variability (HRV, a measure of parasympathetic cardiac activi‐
ty),  diastolic and systolic blood pressure (DBP; SBP) and electric skin conductance. Plas‐
ma levels of adrenaline derived almost totally from the adrenal medulla, whereas plasma
noradrenaline derived in part  from the adrenal medulla but mostly from the activity of
sympathetic  nerves  in  all  body.  It  is  well-established  that  both  plasma  adrenaline  and
noradrenaline increases in response to emotional stressors,  but the former better reflects
the intensity of emotional stressors [29]. As circulating adrenaline is the main factor con‐
trolling  stress-induced  hyperglycaemia,  it  is  not  surprising  that  plasma  glucose  is  a
marker of stress intensity under moderate to strong stressful conditions [29].
The HPA axis is a complex and dynamic system whose regulation has been very well-char‐
acterized in the last decades [30]. The main brain locus of control of the HPA axis is the par‐
aventricular nucleus of the hypothalamus (PVN). The PVN is a complex nucleus with two
main types of neurons and several subdivisions. Big (magnocellular) neurons are located in
the PVNm and synthesize the neurohypophyseal hormones oxytocin and vasopressin (VP),
sending axons directly to the neurohypophysis. Small (parvocellular) neurons are concen‐
trated in the PVNp and send axons to the median eminence to release ACTH secretagogues
into the pituitary portal blood. Among such secretagogues, the corticotropin releasing factor
(hormone) (CRF or CRH) is considered to be the most important in that it controls both syn‐
thesis and release of the adrenocorticotropic hormone (ACTH) and other peptides derived
from pro-opiomelanocortin (POMC) in anterior pituitary corticotrope cells. Among the oth‐
er ACTH secretagogues, VP appears to play a prominent role, acting synergistically with
CRH to increase the release (but not the synthesis) of ACTH. In the PVNp appears to be two
different populations of CRH neurons, one co-expressing and another one non-coexpressing
VP. Interestingly, persistent or repeated activation of the HPA axis is accompanied by an in‐
crease in the number of CRH neurons coexpressing VP in the PVNp, suggesting a more
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prominent role of VP in those situations associated to hyperactivity of the HPA axis. CRH in
the anterior pituitary acts through CRH type 1 receptors (CRH-R1), whereas VP acts
through AVP1b receptors. In addition to the above considerations, it should be taken into
account that the contribution of CRF, VP and other secretagogues to the release of HPA hor‐
mones appears to be dependent on the particular type of stressor.
When the animals are exposed to stressful situations ACTH is promptly released (a few mi‐
nutes), reaching a maximum between 5-10 minutes after a brief exposure to stressors or be‐
tween 15-30 minutes with more prolonged exposures. Plasma levels of ACTH may well
reflect a wide range of stressor intensities provided that samples are taken at appropriate
times after the initial exposure to the stressor [29]. If exposure to a stressor lasts only a few
minutes, maximal ACTH levels are achieved in a period of 5-10 minutes, then declining. If
exposure to the stressor continues and it is relatively severe, the ACTH response is main‐
tained for about 1 h but not more, and, therefore, plasma levels of ACTH are no longer a
reflection of stressor intensity. One critical point regarding stress-induced adrenocortical se‐
cretion is that the maximum is reached with relatively low levels of ACTH so that plasma
levels of glucocorticoids are only a good reflection of ACTH release with low intensity stres‐
sors. In fact, differences in plasma levels of corticosterone immediately after exposure to rel‐
atively severe stressors (i.e. footshock, restraint, immobilization) reflect more the maximal
capability of the adrenal to secrete glucocorticoids, which is related to the adrenal weight
[i.e. 31], rather than the circulating levels of ACTH, thus leading to a frequent misinterpreta‐
tion of the results.
On the basis of the above, two major points should be considered in evaluating the impact
of a stressor on the HPA axis. Firstly, measurement of circulating levels of glucocorticoids at
a time shorter than 15 minutes after initial exposure to stress is non-appropriate to reflect
the actual impact of a stressor on adrenocortical secretion because maximum levels are ach‐
ieved nearly and beyond this time point. Secondly, plasma levels of glucocorticoids are not a
reflection of stressor intensity above a certain level of intensity, which usually lies within
low to moderate range. In the rat, exposure to a relatively stressful novel environment is
probably the situation above which glucocorticoids hardly can detect actual anterior pituita‐
ry activation. Although, plasma glucocorticoids levels just after stress did not reflect ACTH
levels, the follow-up of their plasma levels for a period of time after the termination of stress
can reflect the initial ACTH release and therefore should be used in those cases where there
is no possibility to directly measure ACTH.
Glucocorticoids release by stress exerts a wide range of actions in the body, both peripheral‐
ly and centrally. These effects are exerted through genomic and non-genomic processes [32,
33]. Genomic effects of glucocorticoids are exerted through two well-characterized recep‐
tors: mineralocorticoid (MR, type I) and glucocorticoid (GR, type II) receptors. The non-ge‐
nomic receptors are still uncharacterized at the molecular level, but are likely to be located
in plasmatic membrane. Regarding the regulation of the HPA axis, one major function of
glucocorticoids is to exert a negative feedback to reduce initial activation of the HPA axis.
This negative feedback [34] is exerted at different levels: at the anterior pituitary, at the PVN
and at other key brain areas such as the hippocampal formation and the prefrontal cortex
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[30]. The negative glucocorticoid feedback controls both normal resting activity of the HPA
axis and the response to stressors. Since a defective negative feedback can markedly alter
HPA functioning, there are classical tests for the efficacy of such feedback that use exoge‐
nous administration of natural or synthetid glucorticoids. In humans, it is extensively used
the administration of the synthetic glucocorticoid dexamethasone (DEX) in the so called
suppression DEX test. However, the validity of this test has been questioned by the fact that
DEX, which easily penetrated the brain, is excluded from the brain by the multi-drug resist‐
ant protein P-glycoprotein [35]. Therefore, depending on the dose DEX mainly acts at the
pituitary and only to a limited extent within the brain.
The HPA axis shows both circadian and pulsatile rhythms [36]. In addition to its biological
meaning, the existence of a pulsatile secretion of ACTH and corticosterone is an important
concern when only one sample is taken as it could not be representative of the actual secre‐
tion. Regarding circadian rhythm, maximum activity is observed around the awakening
time. Maximum levels of plasma glucocorticoids are associated in all animals and humans
to the start of the active period, being observed just around lights off in rats and mice and
just after sleep in humans. Although the circadian rhythm affects both ACTH and glucocor‐
ticoids, the amplitude is much greater for the latter than for ACTH due to an increase in
adrenal sensitivity to circulating ACTH [37]. In humans, there is a sharp increase in the first
30 minutes after awakening (called the cortisol awakening response, CAR) followed by a
progressive decline over the day [38, 39]. Both in animals and humans, proper evaluation of
the HPA axis requires taking several samples over the day.
Measurement of plasma levels of ACTH and corticosterone under resting (basal) conditions
and after exposure to stress is the simplest approach when studying the functionality of the
HPA axis. It is important to note that altered responsiveness of HPA hormones to stress can
be observed with normal resting levels, but increased responsiveness to stressors may even‐
tually result in increased resting levels of plasma glucocorticoids. However, these measures
are very often insufficient for a deeper understanding of HPA differences between individu‐
als or between different physiological or pathological conditions. Other classical measures
include the evaluation of: (a) adrenal responsiveness to ACTH by administering exogenous
ACTH and measuring plasma levels of cortisol or corticosterone; (b) adrenocorticotrope cell
responsiveness to CRH and VP by exogenous administration of these neurohormones and
measurement of plasma levels of glucocorticoids and preferable of ACTH; (c) the integrity
of negative glucocorticoid feedback mechanisms, usually by given DEX. More recently, the
combined DEX-CRH test has gained considerable interest, although the biological processes
underlying this test are not well-understood. In animals, we can obviously use a wide range
of additional approaches, but the most used are the evaluation of the brain expression of
those neuropeptides directly related to the regulation of the HPA axis. If some subjects re‐
spond more to stress, it is assumed that they will ideally show enhanced PVN expression of
CRH and/or VP, enhanced AP expression of the POMC gene, increased adrenal weight and
perhaps higher resting levels of plasma glucocorticoids and reduced efficacy of negative
glucocorticoid feedback. This is a typical pattern after exposure of animals to chronic severe
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stressors [40]; however, it is realistic to assume that this whole pattern would be rarely
found in humans.
Individual differences in some of the components of this complex biological system may op‐
pose to the expected results, complicating the interpretation of the results. For instance, a
highly emotional rat or mouse strain may be characterized by a physiological defect in the
HPA axis (i.e. defective CRH production, reduced adrenocortical responsiveness to ACTH)
that would act in the opposite direction to emotionality thus cancelling the differences in
particular hormonal output. This is the case of inbred Lewis rats. They are considered as
highly emotional [4], but are also characterized by a defective HPA system thus resulting in
reduced ACTH and corticosterone response to a wide range of stressors (i.e. 41, 42). There‐
fore, if we expect higher HPA activation in these emotional animals (a hypothesis that is not
necessarily true), defective HPA function could mask the expected higher HPA response.
This problem is particularly important when comparing inbred animals.
In addition to the HPA axis, all anterior pituitary hormones (growth hormone, GH, thyro‐
tropin stimulating hormone, TSH, prolactin, luteinizing hormone, LH, and follicle-stimulat‐
ing hormone, FSH) have been extensively studied regarding stress and psychopathology.
However, in recent decades, the interest focused on the HPA axis and to lower extent in pro‐
lactin. Prolactin is a stress-responsive hormone that is regulated by two hypothalamic mech‐
anisms [43]. One involves a potent and tonic inhibitory control by a population of
dopaminergic neurons located in the arcuate nucleus that send axons to the pituitary portal
blood (tuberoinfundibular system). The other involves one or several prolactin releasing fac‐
tors (PRFs). There are several candidates as PRFs, including oxytocin and VP, but there is no
still agreement about the actual PRF. It is likely that during stress, prolactin release is the
consequence of the reduction of dopaminergic inhibitory signals and the increase in stimula‐
tory inputs. Although the precise role of prolactin during stress is not known, there is evi‐
dence that peripheral prolactin has access to the brain through prolactin receptors and can
exert anxiolytic and anti-stress effects [44].
1.3. Are the intensity and nature of the stressor important for characterizing individual
differences?
Which are the objectives of characterizing individual differences in responsiveness to stres‐
sors? One important purpose is to associate altered physiological responsiveness to patho‐
logical conditions: i.e., increased cortisol response to stressors may underlie immune
suppression. Another one is to establish whether or not certain individuals or psychopathol‐
ogies are characterized by an altered sensitivity to stressors. In the latter case, we assume
that the chosen physiological variable is able to distinguish between hypo- or hyper-respon‐
sive subjects. However, to accomplish this goal we need to demonstrate first that these vari‐
ables are able to reflect the intensity of stressors and that the results are relatively unaffected
by the type (quality) of stressor. In animals, on the basis of neuronal activation as revealed
by c-fos and lesion experiments it appears that those stressors having a predominant emo‐
tional component (i.e. electric shock, restraint, immobilization, exposure to predator or pred‐
ator odors) activate the HPA axis following telencephalic pathways, whereas stressors
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having a predominantly physical component (endotoxin, cytokines, hemorrhage) act pri‐
marly at the level of the brainstem, brainstem nuclei sending stimulatory signals to the
PVNp [45, 46]. In fact, recent studies suggest that is likely that each particular stressor can
have a particular brain activation signature, thus leading to differential adaptive behavioral
and physiological responses and pathological consequences [47]. Nevertheless, it has been
demonstrated in rats and mice that in response to predominantly emotional stressors, plas‐
ma levels of adrenaline, noradrenaline, ACTH, corticosterone (under certain conditions) and
prolactin reflect, under appropriate conditions, the intensity of stressors [29]. In contrast,
whereas circulating levels of some other anterior pituitary hormones (GH, TSH, LH) are al‐
tered by stress in animals and humans [i.e. 48-51], there is no evidence that they are sensi‐
tive to the intensity of stressors. In rats, we have found a very consistent correlation between
the ACTH or corticosterone response to different novel environments [52, 53], whereas no
correlation at all when comparing the response to a novel environment and to a much more
severe stressor such as immobilization (unpublished). Whether or not the critical factor for
the lost of correlation is the markedly different intensity of the two stressors or the qualita‐
tive differences among them is unclear.
In humans, despite the extensive human literature on stress, there have been few attempts to
establish which physiological variables may be sensitive to the intensity of emotional stres‐
sors. Callister [54] used two tests (a modified Stroop colour word test and mental arithmetic
task) each with different levels of difficulty over one unique session and observed progres‐
sive increases in the perceived stress in function of the difficulty; in contrast, HR was inde‐
pendent and DBP and SBP promptly achieved a plateau with relatively low levels of
intensity. Therefore, there is negative evidence for a relationship between HR and level of
stress and limited evidence regarding blood pressure. In our own work we compared in
Medicine female students the anxiety, cortisol, prolactin and glucose responses to two ex‐
ams (Psychology and Physiology) that were known to induce different levels of anxiety [55].
As expected, state anxiety increased in response to both exams as compared to a regular
day, but anxiety was greater with Physiology. The response to plasma cortisol was low, but
in the same direction, whereas prolactin not only increased with respect to the routine day,
but the increase was greater with Physiology than Psychology exam. In another study, sali‐
vary cortisol appears to reflect the degree of stress when assessed in different situations dur‐
ing military survival training [56]. These data support the hypothesis that biological stress
markers are likely to behave similarly in humans and rodents. Interestingly, despite the par‐
allel behaviour of state anxiety, cortisol and prolactin, no significant correlation was ob‐
served between the variables in our work [55], suggesting parallel but in great part
independent regulation. The Trier social stress test (TSST) is an extensively used psychoso‐
cial stress that includes public speech and evaluation [57]. Subjects classified as high or low
responders in function of the ACTH and cortisol responses to the TSST did not differ in their
HR, adrenaline or noradrenaline responses [58]. This suggests that classification of subjects
was based more on a specific functional difference in the regulation of the HPA or on indi‐
vidual differences in stress responsiveness that only affected the HPA axis, not reflecting a
general stress hyper-responsiveness.
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In sum, the available results are not suggestive of a stressor-independent pattern of response
of the HPA axis and other variables that could unequivocally characterize individuals. That
is, individual differences in physiological responsiveness to stressors are not only depend‐
ing on certain characteristics of the individuals, but also on the particular stressor used as a
challenge. Interestingly, attention should be paid as to how subjects can experience different
emotional reactions to the same stressful situations. Thus, it was observed in healthy sub‐
jects a differential emotional response (evaluated by facial expression) to a mental arithmetic
task that translated to a differential cardiovascular and salivary cortisol response [59]. In
contrast, self-reported emotional experience did not contribute to such differential physio‐
logical response.
2. Neuroendocrinology of anxiety in humans
2.1. General considerations
In evaluating the neuroendocrinology of anxiety we can take some critical points into con‐
sideration. First, is there any relationship between state anxiety and certain hormones in re‐
sponse to some acute aversive situations? Second, is there any relationship between trait
anxiety in a non-pathological population and resting or stress levels of hormones? Third, are
resting or stress levels of hormones altered in pathological anxiety?
It is well-known in humans that exposure to acute stress can induce physiological (including
hormonal) changes and increased anxiety, with a pattern quite similar to that observed in
animals. However, there are numerous inconsistencies in the literature regarding the re‐
sponse of cortisol or prolactin to stressors. This is likely to be due to our poor knowledge on
the dose-response relationship between stressor intensity and the elicited physiological and
anxious responses in humans. The characterization of the dose-response curves of stressor
intensity and physiological variables is critical for three main reasons. First, we can identify
which physiological variables are actually sensitive to the intensity of stressors, thus ruling
out those which are not. Second, we need to know which range of intensity of stressors can
be appropriately evaluated using a particular variable. For instance, we know that in ro‐
dents plasma corticosterone is useful for low to intermediate intensity stressors but not for
the intermediate-severe intensities, whereas the opposite is true for plasma glucose. Third, if
the physiological response is well-characterized, this can help to objectively place any exper‐
imental stressful situation within the stress scale. Finally, and importantly, if we are using
experimental situations eliciting a modest (or a very high) physiological response, the char‐
acterization of individual differences should be theoretically more difficult. This is particu‐
larly critical when the experimental conditions only elicited an extremely low, if any,
response as appear to be the case in an important number of papers [for review, see 60].
In analyzing the literature about individual differences in responsiveness to stressful lab‐
oratory  tasks,  it  is  important  to  consider  the  importance  of  pre-task  hormone  levels.  It
has been repeatedly observed that  some physiological  markers of  stress are elevated by
the anticipation of the task rather than by the task itself. This sometimes leads to misin‐
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terpretation of the results as a reduced response to the task. In fact, anticipatory anxiety
and physiological response may be indicative of high rather than reduced responsiveness
to putative stressful situations.
2.2. Neuroendocrinology of anxiety in healthy subjects
Unless  otherwise  stated,  differences  in  trait  or  state  anxiety  were  evaluated  with  the
well-characterized  STAI.  We  will  comment  first  data  regarding  state  anxiety  and  then
trait anxiety.
Although numerous studies have demonstrated increases in both state anxiety and some
physiological parameters in response to stressful situations, only few studies reported corre‐
lation between them. In an important number of studies correlation between state anxiety
and some hormones was low or absent, suggesting that despite the apparent parallelism,
underlying factors are likely to differ. In response to anticipation of surgery a significant cor‐
relation was observed between state anxiety and cortisol, but not prolactin [61]. In contrast,
no association between anxiety and the increases in cortisol, prolactin or TSH levels were
observed after parachute jumping [50]. In our own work with exam stress, no significant
correlation was found between state STAI anxiety and plasma cortisol or prolactin levels
[55]. Similarly, in a speech task, some correlations were found between certain physiological
parameters (HR, BP, noradrenaline, cortisol), but not between them and state anxiety [62].
Pottier et al [63] observed in medical students that consultation in an unfamiliar ambulatory
setting caused more anxiety (as evaluated by the STAI and a visual analog scale, VAS) and
salivary cortisol response than consultation in a familiar (in-hospital) setting, but no correla‐
tion was found between the two measures. Similarly, VAS anxiety did not appear to predict
changes in cortisol or HR response to the TSST test in young males whereas perceived stress
did [64]. A study with arithmetic stress observed significant correlation between state anxi‐
ety and salivary α-amylase, but not cortisol or chromogranin-A [65]. Salivary α-amylase and
chromogranin-A both reflect SMA activation, but it is possible that salivary α-amylase rep‐
resents a specific component of SMA activation more closely related to anxiety than other
SMA markers and cortisol. In contrast to most of the previous results, a study evaluating in
surgeons the physiological and STAI response to 54 different surgical procedures (some of
them not perceived as stressful) observed significant correlations between STAI and HR or
salivary cortisol, and between HR and cortisol [66].
In conclusion, the above results did not reveal a consistent positive relationship between
state anxiety and physiological response to stressors. One theoretical explanation for the in‐
consistencies may be explained by the type of data incorporated to the measurement of cor‐
relation. If we include data corresponding to different stressful situations differing in
intensity and, therefore, in the magnitude of the response of certain variables (i.e. anxiety
and cortisol), obviously both variables would increase in parallel. Consequently, a positive
correlation should be observed (Fig. 1). In contrast, if we consider only the same data corre‐
sponding to each particular stressful situation, no correlation could be observed. In addition,
there are other possibilities to explain this lack of consistent relationship. Firstly, failure to
find association may be due to methodological problems such as the clearly different dy‐
Searching for Biological Markers of Personality: Are There Neuroendocrine Markers of Anxiety?
http://dx.doi.org/10.5772/53925
81
namics of each variable that make it very difficult to design experiments optimizing all vari‐
ables. Secondly, physiological variables may capture specific psychological processes, only
some of them being more specifically related to measures of anxiety. Finally, dissociation
may exist between subjective and physiological measures of emotion. For instance, invasive
cardiologists showed increased anxiety response when they adopted a secondary assistant
(teaching) than a primary operator (autonomous) role, but this subjective state was not asso‐
ciated to higher HR and salivary cortisol responses [67].
Figure 1. Correlation between two physiological measures (ACTH and prolactin, PRL) in a simulated response to three
stressors of different intensity: a novel environment, restraint in tubes, and immobilization on boards (IMO). It should
be noticed than when all samples are considered there is a positive statistical significant correlation between the two
hormones, whereas no correlation at all was found when only samples corresponding to the same stressor were stud‐
ied. This can explain inconsistencies in the literature regarding correlations between physiological variables and be‐
tween them and state anxiety.
Regarding trait anxiety, there is negative evidence for an association between trait anxiety
and salivary cortisol response to a speech task or the TSST in adult males [68. 69]. In a study
that compared the response to the TSST of controls and patients with chronic atopic disease,
the lack of relationship between trait-anxiety and salivary cortisol was confirmed and ex‐
tended to plasma levels of ACTH [70]. Similarly, no relationship was found between trait
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and state anxiety and salivary amylase and cortisol responses to TSST or electrical stimula‐
tion either in males or females [71]. Surprisingly, some authors have reported a negative
rather than positive relationship between trait anxiety and stress responsiveness. Healthy
subjects classified as highly anxious showed a diminished salivary cortisol response to an
unpleasant film as compared to low anxiety subjects [72]. This result has been extended in
two studies showing lower plasma ACTH, cortisol, prolactin, adrenaline and noradrenaline
in response to psychosocial stress (public speech) in anxious versus non-anxious subjects
[73, 74]. Moreover, similar results were obtained using the Hospital Anxiety and Depression
Scale that evaluated BP, HR and salivary cortisol responses to a combined (Stroop test, mir‐
ror-tracing and speech) psychosocial stressor [75]. The above data thus suggest a negative
rather than positive relationship between neuroendocrine markers and trait anxiety, al‐
though neurobiological underpinnings are unknown.
The relationship between trait anxiety and resting activity of the HPA axis has also attracted
attention. There is no association with basal salivary evening cortisol [76] or the cortisol re‐
sponse to the DEX+CRH test [77]. However, trait anxiety appears to affect the circadian
rhythm of salivary cortisol in military men under free-living conditions, those with high
trait anxiety displaying less pronounced decreased from early morning to mid-morning [78].
In post-pubertal adolescents, high trait anxiety resulted in higher evening salivary cortisol
with no differences in morning levels [79]. Taken together, trait anxiety may be associated to
a dysregulation of circadian resting cortisol levels, particularly the decline over the waking
period, although there are discrepancies in the details. Studies measuring ACTH are needed
to discern between ACTH-dependent or ACTH-independent dysregulation.
Interestingly, in response to a stressful video (corneal transplant) where higher and faster
increased was observed in saliva α-amylase than in cortisol, a significant positive correlation
was observed between trait anxiety and α-amylase, but not cortisol [80]. A recent report in
children exposed to 3 consecutive stressors (including performance and peer rejection) con‐
firmed the positive relationship of trait anxiety (measured by the revised children’s manifest
anxiety scale) and baseline or stress levels of α-amylase [81]. Considering the previously dis‐
cussed positive relationship between α-amylase and state anxiety, this parameter offers
promising results in studies of anxiety.
2.3. Neuroendocrinology of anxiety disorders
The relationship between anxiety disorders and basal (non-stress) levels of classical stress
hormones is not clear. There are different types of anxiety disorders, as defined by the DSM-
IVR [82]: Panic attacks, agoraphobia, social phobia, obsessive-compulsive disorder, post-
traumatic stress disorder and generalized anxiety disorder (GAD). We will focus mainly in
GAD on this aspect as an example among the different anxiety disorders.
Measures of urinary cortisol give inconsistent results, whereas higher catecholamine content
appears to be more consistent in patients (see review of earlier works in [83]). Plasma prolac‐
tin was found to be normal in early studies [83] and this was further confirmed [84]. Cere‐
brospinal fluid (CSF) levels of CRH are considered as an index of overall activity of brain
CRH neurons, including those neuronal CRH populations not directly related to the regula‐
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tion of the HPA axis. It appears that CSF CRH levels are not altered in GAD, suggesting nor‐
mal brain CRH function [85]. In addition to the inconsistencies of early studies, data from
some recent studies using salivary cortisol do not offer a clearer picture. In late-life GAD,
increased resting levels of salivary cortisol were observed at several times in the morning
but not the evening and the levels were positively related to the severity of anxiety [86]. In
accordance, slightly higher awakening levels of cortisol were observed in a sample of pa‐
tients with anxiety disorders, the effects being particularly significant in those with panic
disorder with agoraphobia and those showing comorbidity with anxiety and depression
[87]. In contrast, lower CAR was observed in another study with a large cohort of older
adults with several types of anxiety disorders when compared to healthy controls [88]. No
differences were observed at other times. Another study with middle-age people suffering
from GAD showed no differences from controls either in the CAR or in the daily pattern of
cortisol, despite higher levels of α-amylase [89]. Whether or not the inconsistencies are due
to the age of patients or confounding factors is not known, although the latter concern
should be taken into account considering the usually small magnitude of the effects. Quite
interestingly, decreased levels of hair cortisol were recently observed in GAD patients de‐
spite no changes in salivary cortisol over the day under resting conditions [90]. As hair corti‐
sol represents the integration of cortisol release over periods of months, the results support a
negative relationship between GAD and HPA activity. It is unclear whether these patients
show reduced response to daily stressors (and therefore, less release of cortisol) rather than
reduced resting activity. This hypoactivity of the HPA axis does not appear to be a general
characteristic of all anxiety disorders. Thus, slightly alterations in circadian and pulsatile se‐
cretion of cortisol and to a lesser extent in ACTH was reported in panic patients, with over‐
all higher levels as compared to controls and increased amplitude of cortisol pulses [91].
Unfortunately, there are scarce studies on the comparison of the response to stress of GAD
patients as compared to controls. In adolescents with GAD, increases in ACTH, GH and pro‐
lactin (but not noradrenaline, adrenaline and cortisol) were found in the phase of anticipa‐
tion to the task in GAD patients but not in controls [92]. In contrast, no response to the task
was observed.
Phobic subjects offer an interesting model for the study of the relationship between behavio‐
ral reaction to the situation and the concomitant physiological response. Severe anxiety was
reported in patients with phobia to insects and small animals after forced exposure, whereas
no changes were found in prolactin [93]. In a further study, increases in HR, blood pressure
and plasma levels of adrenaline, noradrenaline, cortisol and GH were reported, although the
increases in state anxiety were stronger and did not correlate to physiological responses [94].
The strong dissociation between subjective behavioral arousal and cortisol response to spi‐
der phobia was confirmed in another study comparing phobics and healthy controls [95].
Driving phobics as compared to controls showed increased anticipatory anxiety and cortisol
response to driving, with further increases in anxiety but not cortisol during driving [96].
Moreover, no significant correlation was found between anxiety and cortisol in phobic sub‐
jects. Less clear is the response of social phobia patients to social stimuli. Salivary cortisol
response to the TSST was similar in social phobic adolescent girls than in controls [97]. In
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contrast, in another study, children with social phobia showed greater trait anxiety (meas‐
ured by the STAI for childrens, STAI-C) and also greater state anxiety and cortisol responses
to a public speaking task than controls [98]. In the latter study, trait anxiety was positively
related to cortisol, but it was not described whether both control and patients, which already
differed in trait anxiety, were included in the same analysis. In children with social phobia,
exposure to an adapted TSST resulted in higher baseline and TSTT-induced anxiety (scales
for Iconic self-assessment of anxiety in children) than controls [99]. In physiological terms,
baseline HR was higher and the response to the stressor lower in patients as compared to
controls, whereas salivary cortisol and α-amylase response tended to be lower. Finally, a
study comparing healthy controls, social phobia and post-traumatic stress (PTSD) patients
showed higher salivary cortisol response to the TSST in social phobics as compared to con‐
trols and PTSD [100]. The authors also reported a positive correlation between cortisol re‐
sponse to the TSST and avoidance of angry faces in social phobics but not in controls. Taken
together, all those data suggest at least a lower physiological than subjective response to the
phobic situations.
Perhaps the strongest evidence for dissociation between subjective and physiological re‐
sponses comes from patients with panic disorder. These patients have been studied during
spontaneous panic attacks, after pharmacological provocation of panic attacks or in re‐
sponse to different types of stressors. During spontaneous attacks, despite strong subjective
anxiety and physiological signs, changes in HR were not strong and changes in hormones
(noradrenaline, adrenaline, GH and cortisol) were low and inconsistent, being the increases
in prolactin the most consistent [83, 101]. When agoraphobic subjects were exposed to the
phobic situation to trigger a panic attack, most of them experienced panic attacks while con‐
trol subjects did not [102], but only the HR was higher in patients than in controls, whereas
other measures (i.e. blood pressure, cortisol, prolactin or GH) did not differ. There are sever‐
al pharmacological manipulations (i.e., lactate, CO2 inhalation, cholecistokinin-4, pentagas‐
trin, doxapram or meta-chlorophenylpiperazine, m-CPP) that have been demonstrated to
induce panic attacks only in a few healthy subjects, whereas they strongly induce panic at‐
tacks in almost all panic patients. This experimentally controlled approach has been exten‐
sively used to compare the physiological response (including GH, prolactin and cortisol) of
panic patients and control subjects, but the results are difficult to interpret because of the
effects of these manipulations on physiological variables. For instance, m-CPP is a serotoni‐
nergic drug that can pharmacologically induce the release of cortisol and GH. If the greater
panicogenic effect of the drug on panic patients is paralleled by a greater cortisol and GH
release [103], this can be interpreted as a parallelism between the subjective state and hor‐
mones, but also as a putative sensitization of brain serotoninergic pathways controlling
these hormones in panic patients. Nevertheless, the overall conclusion is again that there are
no parallelism between the strong anxiety- and panic-inducing effects of these manipula‐
tions in panic patients as compared to controls and the physiological response [104-111].
Finally,  some studies  aimed at  characterizing  the  physiological  response  to  stressors  in
panic patients.  Fully remitted,  medication-free panic patients exposed to a mild psycho‐
logical stressor showed a clear anticipatory DBP response and a greater cortisol response
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to the stressor as compared to a normal population [112].  In another study, in response
to  public  speaking,  anticipatory  anxiety  developed  in  medication-free  symptomatic  pa‐
tients as compared to normal subjects,  whereas the anxiety response to the actual  stres‐
sor  was lower [113].  Salivary cortisol  showed an anticipatory response,  with no further
response to the stressor [114],  whereas a permanently higher (anticipatory) skin conduc‐
tance was observed in patients  that  did not  further  respond at  all  to  the stressor  [113].
No differences were observed in HR, DBP and SBP. The anticipatory plasma or salivary
cortisol responses were not detected in a study using the TSST as the stressor that never‐
theless showed markedly reduced plasma and saliva cortisol responses in panic patients
as compared to controls,  associated to a normal HR response [115].  In a very recent re‐
port  using mild  shocks  as  the  stressor,  the  anxiety  and salivary  cortisol  and α-amylase
response  was  studied  in  panic  patients  as  compared  to  controls  [116].  Then,  patients
were treated with the benzodiazepine anxiolytic  alprazolam and classified as  responder
and non-responder  to  the therapy.  When the two groups of  patients  and controls  were
retrospectively  compared,  it  was  found a  similar  anticipatory  increase  in  anxiety  in  the
two groups of  patients  as  compared to  controls,  but  an anticipatory increase in  α-amy‐
lase (but not in cortisol), only in those panic patients who further responded to the ther‐
apy  with  alprazolam.  The  similar  state  anxiety  response  of  responders  and  non-
responders  accompanied  by  a  differential  anticipatory  cortisol  and  α-amylase  response
demonstrates again the dissociation between subjective and physiological measures.
Table 1 summarizes the relationship between anxiety and the neuroendocrine response to
stressors in healthy people and with anxiety disorders. The experimental data indicate a lack
of parallelism between subjective state or trait anxiety and neuroendocrine response to stres‐
sors in healthy subjects. In fact, there is some evidence for a negative relationship between
trait anxiety and physiological response to stressors. Regarding anxiety disorders, a negative
relationship is frequently observed in panic and GAD patients, and a lack of association in
social phobia.
3. Emotionality, anxiety and neuroendocrine markers in selected rat lines
3.1. Selection on the basis of defecation rate: Maudsley reactive (MR) and Maudsley non-
reactive (MRN) rats
The first genetic selection of a putative emotional strain of rats used the criterium of defeca‐
tion rate in a novel, stressful, environment (an open-field) and led to the characterization of
high defecation rate (MR) and low defecation (MRN) lines [see 117]. This selection also re‐
sulted in lower activity in the open-field of MR as compared to MNR rats, thus supporting
the hypothesis that emotional animals would display a lower level of activity in a stressful,
environment. However, it soon became evident that the relationship between defecation rate
and activity in the open-field was more controversial than previously assumed and of much
lower magnitude than that of defecation. In addition, not consistent differences have been
observed in other anxiety test, including the EPM, the acoustic startle response (ASR), the
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light-dark test and the shock-induced conditioned suppression of appetitive operant task
[118-121] perhaps related to the existence of two different stocks of rats (UK and USA). Un‐
fortunately, there only two reports comparing the HPA response in the two strains: Abel et
al [122] found no differences in plasma corticosterone levels after 10 minutes of exposure to
an open-field or to forced swimming. However, Kosti et al. [123] observed greater ACTH re‐
sponse to restraint in MR vs MNR, despite no differences in plasma corticosterone. This ap‐
parent discrepancy is likely to be due to increased corticosterone responsiveness to ACTH in
MNR. Therefore, MR and MNR, which differ in some aspects of emotionality but not clearly
in anxiety-like behaviour, did appear to show differences in HPA function.
Population
Physiological system
SMA HPA PRL
Healthy subjects
State anxiety ≈ * ≈ ≈
Trait anxiety ≈ /↓ ≈ /↓ ≈ /↓
Anxiety disorders
GAD ↓ A /↓ A /↓
Phobia
phobic Ss others phobic Ss others phobic Ss others
↓ ? ↓ ? ↓ ?
Social phobia ≈ ? ≈ ? ? ?
Panic
panic attack others panic attack others panic attack others
↓ A /↓ ↓ A /↓ ↓ ?
≈ : no correlation or approximately normal response (* except α - amylase, see main text)
↓: reduced, at least with respect to subjective anxiety
A : anticipatory response
Ss: stimuli
? : not tested
PRL : prolactin
Table 1. Relationship between normal or pathological anxiety and physiological response to stress.
3.2. Selection on the basis of the EPM: high anxiety and low anxiety rats (HAB, LAB)
The only specific selection process aiming at selecting two strains of rats strongly differing
in their performance in the EPM, the most widely used test for anxiety, has resulted in HAB
and LAB rats, the former displaying very low levels of exploration of the open arms of the
plus-maze [124]. In addition, HAB rats spent less time in light and make less number of
transitions in a dark-light test, and also spent less time in the social interaction test [125],
confirming differences in anxiety. It is important to note that HAB rats are less active in the
forced swimming test [124, 126], a classical test to evaluate antidepressants [127], which pre‐
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sumably evaluates passive-active coping strategies [128]. Therefore, HAB rat appear to be
prone to use passive coping strategies and to depression-like behavior.
HAB showed greater ACTH and corticosterone responses than LAB, mainly when the ani‐
mals are forced to remain in the open arms (more stressful than the closed arms) of the EPM
[129], but not when they can freely explore both open and closed arms [124]. Moreover, no
differences were observed in the ACTH and corticosterone responses to forced swim, de‐
spite differences in behaviour [124]. Surprisingly, HAB rats showed lower ACTH response
than LAB to social defeat [130], demonstrating that differences in responsiveness to stress
was dependent on the particular type of stressor used. Therefore, extreme differences in
anxiety, evaluated by the EPM, only resulted in consistent differences in the HPA response
to situations similar to those that serves as criteria for selection. When exposed to other sit‐
uations, the results can markedly change. These data are very important because they sug‐
gest that individual differences in HPA responsiveness to stress are critically dependent on
the type of stressor used.
HAB-LAB rats likely represent the most complete characterization of genetic differences in
the HPA axis. In several reports it has been demonstrated enhanced VP gene expression in
the PVN, affecting both magnocellular and parvocellular subdivisions [131]. In another re‐
port, enhanced PVN CRH expression was also observed [132]. These data suggest increased
drive to the corticotrope cells, what is supported by an enhanced POMC gene expression in
the anterior pituitary [133]. No differences were observed in CRH-R1 in the anterior pituita‐
ry, whereas there were increases in CRH-R2 (the other type of CRH receptor) and V1b re‐
ceptors in the HAB rats [134]. It is quite possible that VP is responsible for the enhanced
ACTH response to the DEX+CRH test in HAB rats [131], as the ACTH response to the mere
administration of exogenous CRH was normal [135] and there are no differences between
lines in the expression of GR in the anterior pituitary [131, 133]. Although most of the above
described changes in the central aspects of the HPA axis may be better ascribed to depres‐
sion-like rather than anxiety-like behavior, administration of an VP receptor antagonist in
the PVN normalize anxiety-like behaviour of HAB rats [134]. This strongly suggests that en‐
hanced PVN VP expression plays a critical role in anxiety.
The data regarding the PVN and the anterior pituitary would suggest increased drive to the
gland and a generalized greater ACTH response to stress in HAB rats. However, this is not
the case as reported above. A greater adrenal gland is associated in a normal population of
rats with greater maximal corticosterone secretion [31]. Therefore, the increased adrenal cor‐
tex size of HAB rats is compatible with a greater maximal corticosterone secretion. In fact,
HAB rats showed a normal ACTH response to endotoxin accompanied by a greater cortico‐
sterone response [136], which is likely to be maximal secretion under these conditions.
3.3. Selection on the basis of active avoidance performance
Several pairs of rat lines have been obtained on the basis of performance in passive or active
avoidance tasks in a shuttle-box, using electric footshock as the aversive stimulus. Some, but not
all, of these strains appears to differ in emotionality, particularly in fear/anxiety, but is should
be taken into account that even if they actually differed in anxiety, also could differ in other
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traits (i.e. novelty-seeking or depression like behavior) that may affect the neuroendocrine re‐
sponse. These caveats should be taken into consideration in the discussion that follows.
The outbred Roman high avoidance (RHA) and Roman low avoidance (RLA) rats were ob‐
tained by genetic selection on the basis of performance in a two-way active avoidance task [see
20]. Most of the behavioral and endocrinological studies have been obtained in different sub-
stocks of the swiss sublines (RHA/Verh, RLA/Verh) and later by inbred RHA and RLA strains. It
was soon realized that the two lines differed not only in active avoidance, but also in terms of
emotionality, the RLA rats being more emotional than RHA rats. Subsequent research has dem‐
onstrated that the two lines differ in several important behavioral traits, including coping style
and impulsivity [20]. The lines differ in some tests of anxiety more markedly than in others, be‐
ing particularly relevant the inconsistencies regarding the EPM [137].
There have been some discrepancies regarding the responsiveness of the HPA axis to stress
in these strains. In 1982, Gentsch et al. [138] firstly reported that RHA/Verh rats showed
lower ACTH, corticosterone and prolactin responses to mild stressors (i.e. novel environ‐
ments) than RLA/Verh rats, but the differences disappeared with stronger (i.e. ether stress,
footshock, restraint) stressors. However, inconsistent differences were observed in when the
lines were maintained in another laboratory [139, 140]. The study by Walker et al [141] is
one of the most complete characterizations of differences in the HPA axis between the two
lines. Unfortunately, the results are extremely difficult to interpret. Thus, it was found in
RHA as compared to RLA rats: (a) higher adrenal weight; (b) higher basal levels of ACTH
accompanied by normal corticosterone levels; (c) no differences in ACTH levels after 10 mi‐
nutes of exposure to a novel environment or ether (10 minutes), despite an enhanced anteri‐
or pituitary response to exogenous CRH administration; (c) a lower corticosterone response
to stressor despite the normal levels of ACTH and the increased adrenal weight. In addition,
a higher number of GR in the pituitary along with higher MR levels in the hippocampus
was found in RHA rats. The higher number of GR in the anterior pituitary may have con‐
tributed to the reduced ACTH response to CRH, whereas the higher MR in the hippocam‐
pus could be expected, if any, to reduce ACTH response to stress, which was not the case (in
absolute terms) in their paper. In further reports, the early findings of increased ACTH and
corticosterone responsiveness of RLA rats to novel environments were confirmed [137, 142].
Moreover, RLA rats showed normal levels of CRF mRNA, but increased levels of VP mRNA
in the PVNp [142], a pattern observed in situations characterized by a chronic hyperactivity
of the HPA axis. At first glance, the latter results suggest that HPA axis of RLA may be gen‐
erally more responsive to stress than RHA, thus resulting in increased VP gene expression
in the PVN. However, one could expect a greater relative adrenal weight in RLA as a conse‐
quence of the cumulative impact of higher ACTH response to daily events, but the opposite
has been repeatedly found [139, 141, 143]. The possibility remains that the greater adrenal
weight of RHA vs RLA rats is a compensatory mechanisms to maintain appropriate adreno‐
cortical secretion despite some defect at the level of the adrenal.
Genetic analysis of cosegregation of different behavioral and physiological variables in these
lines has allowed to conclude, in accordance with the inconsistency of the HPA data, that pro‐
lactin, but not the variables related to the HPA axis, is probably related to differences in active
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avoidance [143]. Even if RLA are characterized by a greater HPA reactivity, the possible influ‐
ence of behavioral traits other than anxiety on the HPA axis should not be disregarded.
After inbreeding (RHA-I, RLA-I), we have reported normal resting levels of ACTH and cor‐
ticosterone, but increased response of the two hormones to a novel environment [144]. En‐
hanced PVN CRH gene expression, but unaltered VP expression in PVNp and PVNm, was
also observed in RLA-I versus RHA-I. Quite interestingly, enhanced CRH expression in the
RLA-I rats was found in a brain area, the dorsolateral division of the bed nucleus of stria
terminalis (BST). As the BST has been repeatedly implicated in the control of anxiety [13],
our data suggest that extra-PVN changes in CRH gene expression may participate in some
of the behavioral differences between the two strains.
Syracuse Low and Syracuse High avoidance (SLA, SHA) rats, have been also selectively
bred on the basis of their behaviour in an active avoidance task (see [145]). Again, SLA and
SHA rats appear to differ in emotionality. Thus, SLA rats defecate more in an open-field and
show faster learning of a passive avoidance task and more fear conditioned suppression of
appetitive instrumental behaviour than SHA, but no differences were observed in sensitivity
to shock or activity. Unfortunately, it is not known whether they differ in anxiety as evaluat‐
ed by the EPM. In accordance with their greater emotionality, SLA rats show a greater glu‐
cose response to an open-field [146]. However, SLA rats are characterized by modestly
lower corticosterone response to ether stress, but much lower adrenal corticosterone con‐
tent, as compared with SHA [147]. Similar results were observed after exogenous CRH ad‐
ministration [148]. Quite surprisingly, reduced adrenal corticosterone levels occur despite
greater relative adrenal weight and greater size of adrenal cortex in SLA rats [148, 149]. The
most likely explanation is that RLA showed a defective adrenocortical responsiveness to
ACTH that tended to be compensated by increased adrenal mass. Unfortunately, ACTH lev‐
els were not measured in any experiment.
In conclusion, the comparison of the neuroendocrine characteristics of RLA-RHA and SLA-
SHA is limited by the lack of information regarding the last pair of lines. Nevertheless, the
available information does not reveal a homogenous pattern. Accordingly, in mice, the best
performed studied compared several inbred strains of mice in several test for anxiety (EPM,
ASR and hyponeophagia) and in basal and stress levels of corticosterone [150]. Whereas a
good correlation among the strains was observed with the three tests of anxiety, no correla‐
tion was found between anxiety-like behaviour and corticosterone. These data support con‐
clusions in rats.
4. General conclusions
The overall conclusion of the present review is that the physiological response does not re‐
flect concomitant changes in objective anxiety as evaluated by classical tests in laboratory
animals or self-reported measures in humans. There are several reasons that can explain
such dissociation and the sometimes controversial results. First, the uncertainty about the
underlying psychological or behavioral traits of interest and the way we can evaluate them.
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Second, the use of animal lines differing in more than one trait, making difficult to separate
the contribution of anxiety from that of other traits. Third, the different dynamics of the be‐
havioral processes and the physiological variables measured. Four, the possibility that oth‐
ers, still not characterized, biological parameters may be more appropriate as biological
correlates of anxiety. Finally, there are uncertainties about the relationship between subjec‐
tive reports of anxiety and the biological response to aversive stimuli.
In laboratory animals, the classical approach has been the selection of the animals in func‐
tion of particular criterium or test, assuming that this identifies the particular trait of inter‐
est, anxiety for the present discussion. However, it is unrealistic to assume that the selection
of animals on the basis of one single test can really identify one particular trait. In addition,
the experimental evidence strongly indicates that these animals also differ in other different
traits, making it difficult to isolate anxiety for other traits. For instance, HAB-LAB rats not
only differ in anxiety but also in depression-like behavior [124]. Similarly RLA and RHA
rats also differ in impulsivity [137].
The most widely used physiological responses are those related to the SMA and the HPA axis,
in addition to other hormones such as prolactin. The different indices greatly differ in terms of
the time needed to reflect changes in the environment. Cardiovascular changes (i.e. HR, blood
pressure) can rapidly change in one minute, plasma levels of adrenaline and noradrenaline is
also very fast and their half-life is very short, thus resulting in the possibility of marked changes
in periods of 5 minutes. Plasma levels of anterior pituitary hormones are released very fast (a
few minutes), but half-life is longer than that of catecholamines (between 5 and 30 minutes or
more, depending on the particular hormone). Finally, changes in plasma or salivary cortisol are
relatively slow, with maximum no more than 15-30 minutes after the initial exposure to the sit‐
uation. Thus, the dynamics of the response is important when considering the influence of cog‐
nitive processes in the regulation of the emotional response to the situation.
Although more elaborated endocrinological studies may help to elucidate some controver‐
sial results, it is important to look at other physiological variables. For instance, a recent
study observed lower plasma levels of nesfatin-1, a recently characterized satiety molecule,
in GAD patients [151]. Immunological markers are currently studied regarding stress and
personality factors. In one interesting paper in a large population of men and women, anxi‐
ety positively correlated to levels of certain inflammatory markers (C-Reactive Protein, in‐
terleukin-6, Tumor Necrosis Factor-α and fibrinogen) [152]. Characterization of putative
inflammatory markers of anxiety requires further studies.
In humans, psychological traits are complex constructs that involve top-down cognitive
processes. In contrast, physiological response to aversive situations is likely to be reflexive in
nature at least initially. It is possible that both processes are relatively independent. Rapid
attention and responding to putatively threatening stimuli is a characteristic of several anxi‐
ety disorders and healthy people with high neuroticism or trait-anxiety [153]. In a very inter‐
esting study, preconscious and conscious attention biases to emotional stimuli were
evaluated in subjects exposed 4 and 8 months later to a laboratory stressor or to examina‐
tion, respectively [154]. Preconscious negative bias processing was a better predictor of corti‐
sol response than self-reported neuroticism, trait-anxiety or extraversion.
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Another additional problem when addressing human data is the limitation of the informa‐
tion we can obtain from typical laboratory stressors. First, emotional processing of stressors
may be complex and dependent on the particular nature of the situation. Anxiety disorders
may be associated to a differential processing of certain categories of stressors but not all
stressors and therefore information obtain from exposure to standard stressors may be limit‐
ed and different depending on the particular type of anxiety disorder. Second, laboratory
stressors tend to be of lower intensity that some real-life stressors and it is unclear whether
or not we can extrapolate the results from one type to the other.
Even if we can identify physiological variables related to pathological anxiety, an important
concern is whether these variables are the consequence of the pathology or a predisposing
factor. In the last year particular attention has been paid to this problem, but it is still an im‐
portant drawback when analyzing published data.
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